Analysis of HIV-1 gp120 quasispecies suggests high prevalence of intra-subtype recombination

Analysis of HIV-1 gp120 quasispecies suggests high prevalence of intra-subtype recombination

Bibliographic Details
Main Authors:	Kiwelu IE, Novitsky V, Margolin L, Baca J, Manongi R, Sam N, Shao J, MacLane MF, Kapiga SH, Essex M
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies.
by: Ireen E Kiwelu, et al.
Published: (2012-01-01)

Frequent intra-subtype recombination among HIV-1 circulating in Tanzania.
by: Ireen E Kiwelu, et al.
Published: (2013-01-01)

HIV-1 pol diversity among female bar and hotel workers in Northern Tanzania.
by: Ireen E Kiwelu, et al.
Published: (2014-01-01)

Viral quasispecies.
by: Esteban Domingo, et al.
Published: (2019-10-01)

Characterization of gp120 and Its Single-chain Derivatives, gp120-CD4 and gp120-M9: Implications for Targeting the CD4i Epitope in HIV-1 Vaccine Design
by: Shiver John
Published: (2005-12-01)

Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms.
by: Alessandra Cenci, et al.
Published: (2014-01-01)

HIV-1 subtype C primary isolates exhibit high sensitivity to an anti-gp120 RNA aptamer
by: Mufhandu HT, et al.
Published: (2012-09-01)

Pre-S Deletions are Predominant Quasispecies in HIV/HBV Infection: Quasispecies Perspective
by: Nie Y, et al.
Published: (2020-06-01)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
by: Emaya M. Moss, et al.
Published: (2023-02-01)

Quasispecies made simple.
by: J J Bull, et al.
Published: (2005-11-01)

Quasispecies made simple.
Published: (2005-11-01)

P20-12. Heterogeneity of Gag mutational pathways in primary HIV-1 subtype C infection
by: Makhema J, et al.
Published: (2009-10-01)

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
by: Heidi E Drummer, et al.
Published: (2013-01-01)

gp120 Envelope Glycoproteins of HIV-1 Group M Subtype A and Subtype B Differentially Affect Gene Expression in Human Vascular Endothelial Cells
by: Andrew J. Suh, et al.
Published: (2023-02-01)

HIV-1 Subtype C Phylodynamics in the Global Epidemic
by: Max Essex, et al.
Published: (2010-01-01)

HIV-1 subtype C unproductively infects human cardiomyocytes in vitro and induces apoptosis mitigated by an anti-Gp120 aptamer.
by: Walter R Lopes de Campos, et al.
Published: (2014-01-01)

Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity.
by: Jyoti Sutar, et al.
Published: (2021-01-01)

Quantifying In-Host Quasispecies Evolution
by: Josep Gregori, et al.
Published: (2023-01-01)

Characterization of RNA aptamers that bind to HIV-1 gp120
by: Cohen, C
Published: (2006)

Monoclonal antibodies to HIV-1 gp120: a request.
by: Moore, J, et al.
Published: (1993)

STRUCTURAL-ANALYSIS OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
by: Moore, J, et al.
Published: (1993)

Behavioral Evidence for a Tau and HIV-gp120 Interaction
by: Murali Vijayan, et al.
Published: (2022-05-01)

NMR spectroscopy of HIV-1 gp120 outer domain
by: Sastry M, et al.
Published: (2012-09-01)

Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120<sub>V3 </sub>signatures in the regulation of Co-Receptor usage
by: D'Arrigo Roberta, et al.
Published: (2011-05-01)

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
by: Moore, J, et al.
Published: (1995)

Characteristics of HIV-1 gp120 <it>env</it> sequences in mother-child pairs infected with HIV-1 subtype CRF01_AE
by: Hemvuttiphan Jittapol, et al.
Published: (2008-04-01)

Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions
by: Zihao Wang, et al.
Published: (2016-05-01)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
by: Caffrey Michael, et al.
Published: (2004-03-01)

Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
by: Sunil K Khattar, et al.
Published: (2013-01-01)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
by: Hioe Catarina E, et al.
Published: (2008-07-01)

Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
by: Leen Mathys, et al.
Published: (2014-01-01)

Correction: Deletion of the Highly Conserved -Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity.
Published: (2014-01-01)

Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
by: Esser, M, et al.
Published: (1999)

SOLUBLE CD4 BINDING TO HIV-1 VIRIONS CAUSES GP120 TO DISSOCIATE FROM GP41
by: Moore, J, et al.
Published: (1991)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
Published: (2014-01-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector.
by: Sunil K. Khattar, et al.
Published: (2014-01-01)

Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
by: PLOS ONE Editors
Published: (2020-01-01)

HIV gp120: double lock strategy foils host defences.
by: Sattentau, Q
Published: (1998)

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists
by: Francesca Curreli, et al.
Published: (2022-12-01)

Recent Advances in the Molecular and Cellular Mechanisms of gp120-Mediated Neurotoxicity
by: Valeria Avdoshina, et al.
Published: (2022-05-01)